Henry Schein, Inc.

Valuation Analysis

About the Company

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse

Henry Schein, Inc. Stock at a Glance

Henry Schein, Inc. (HSIC) is currently trading at $81.25 with a market capitalization of $9.3B. The trailing P/E ratio stands at 24.55x, with a forward P/E of 13.74x. The 52-week range spans from $61.95 to $89.29; the current price is 9% below the yearly high. Year-over-year revenue growth stands at +6.3%. The net profit margin stands at 2.95%.

💰 Dividend

Henry Schein, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

15 analysts rate Henry Schein, Inc. (HSIC) on consensus: Buy. The average price target is $88.07, implying +8.39% from the current price. Analyst price targets range from $64.00 to $100.00.

Henry Schein, Inc.: The Investment Case in Detail

Henry Schein, Inc. (HSIC) operates in the Healthcare — specifically Medical Distribution — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

With a net margin of just 2.95%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

What to Watch Next

• The forward P/E of 13.74x is meaningfully below the trailing 24.55x — analysts expect earnings to step up; the next earnings release is the test.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (8.63%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Henry Schein, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.